Drug Class
BCL-2 inhibitor
Type
brand
Active Ingredient
venetoclax
📋Overview
Venclexta is a medication that targets and inhibits a protein called BCL-2, which helps certain cancer cells survive. It is primarily associated with the treatment of specific blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). By blocking BCL-2, Venclexta can promote the death of malignant cells. This drug is often used in cases where other therapies may not be effective or suitable.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Venclexta
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.